Web Analytics
หุ้น RGEN (NASDAQ) | REPLIGEN CORPORATION – วิเคราะห์โดย Deepscope
MARKET

Select Market Data Region

RGEN — REPLIGEN CORPORATION (Healthcare >> Medical Instruments & Supplies)

RGEN FAQ

What is RGEN's P/E ratio?

REPLIGEN CORPORATION (RGEN) currently trades at a P/E ratio of 133.60.

What is RGEN's ROE?

REPLIGEN CORPORATION reports a Return on Equity (ROE) of 2.44%.

What is RGEN's dividend yield?

REPLIGEN CORPORATION offers a dividend yield of 0.00%.

What is RGEN's Deepscope Quality Score?

Deepscope rates RGEN's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy RGEN?

Deepscope's AI Timing Score for RGEN is 66 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does RGEN belong to?

REPLIGEN CORPORATION is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange.

Stock Check   *ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.*
(Price: 2026-06-04 | FS: 2026-03-31)

RGEN

REPLIGEN CORPORATION
USD 126.55
4.82 (3.96%) Day Change
133.60
P/E
0.27
D/E
2.4%
ROE
1.8%
ROA
0.00%
Div Yield
-0.76
PEG
USD 126.55
Price
4.82 (3.96%)
Day Change
NEWS SCORE: 98

RGEN มีคุณภาพโดยรวมไม่ดี ( คะแนนปัจจัยพื้นฐาน = 38) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

38

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
P/E ratio ค่อนข้างสูง
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ต่ำกว่าเกณฑ์
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนสินทรัพย์ (ROA) ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ยังไม่ดีนัก และ ประสิทธิภาพการทำกำไร ยังไม่ดีนัก , ...

ปัจจัยทางคุณภาพ 44%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 98
  Magic Formula Rank by ROA
2971
  Magic Formula Rank by ROE
2971
  Magic Formula Rank by ROIC
2972
  Price 126.55
  PBV / Sector
3.26 / 4.37
  Earning Per Share 0.95
  PE / Sector
133.60 / 36.10
  PEG or PE/Growth / Sector
-0.76 / -1.23
  Average 1M Daily Value
138.01 M
GREAT
  Average 1W Daily Value
95.13 M
ปัจจัยทางเทคนิค 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
สุขภาพทางการเงิน 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ประสิทธิภาพการทำกำไร 52%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
6.73 / 89.21
  NPM Average (%) / Sector
7.81 / 31.62
  NPM Change Average (%) / Sector
-124.19 / 221.46
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
1.75 / 8.71
  ROA Average (%) / Sector
2.27 / -23.75
  ROA Change Average (%) / Sector
-129.81 / 110.99
  ROE (%) / Sector
2.44 / 11.02
  ROE Average (%) / Sector
3.06 / 425.31
  ROE Change Average (%) / Sector
-128.50 / 113.27
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
ผลตอบแทนต่อผู้ถือหุ้น 4%
X
  Dividend (%) / Sector
N/A / 1.11
  Dividend Average (%) / Sector
N/A / 1.44
  Dividend Change Average (%) / Sector
N/A / 15.03
รายละเอียดการจดทะเบียน
X
  Analyze Date 2026-06-05 09:11:58
  Symbol RGEN
  Name REPLIGEN CORPORATION
  Sector Healthcare >> Medical Instruments & Supplies
  Market NASDAQ
  Listed Shares 56.41 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 6,866.51 / 15,809.81
ข่าว, ประมาณการ, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: Building 1, Waltham, MA, United States, 02453

Phone: 781 250 0111

Website: https://www.repligen.com

Employees: 2,000

Sector: Healthcare >> Medical Instruments & Supplies

Description: Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

ME vs SECTOR Healthcare >> Medical Instruments & Supplies

RGEN (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
RGEN
RGEN
USD 126.55 (3.96%)
+ Watch + Port Chart